News

Blog y noticias

Mida-blog-bonica-gran-1200x675.png
22/May/2024

Veterinary ophthalmology is a complex and constantly evolving field, where research, innovation and collaboration are key to advancing pet eye care.

As passionate as we are about animal welfare and eye health, we are proud to announce our participation as sponsors of the 2024 European Congress of the European Association of Veterinary Ophthalmology (ECVO). This annual event is the epicenter of veterinary ophthalmology in Europe, bringing together the best specialists, researchers and practitioners in the field to share knowledge, present scientific advances and make meaningful connections.

Each year, ECVO hosts its annual congress in a major European city, providing a unique platform for the exchange of ideas, discussion of clinical cases and continuous learning. Over four intense days, the congress covers a wide range of topics related to veterinary ophthalmology, from the presentation of pioneering research to the discussion of innovative surgical techniques.

The 2024 program

The 2024 European Association of Veterinary Ophthalmology (ECVO) Congress promises to be exceptional, with a special focus on exotic animal ophthalmology. Under the theme “Ophthalmology of Exotic Animals,” the continuing education program and master class will explore the anatomical and physiological peculiarities of the eyes of reptiles, birds, rabbits and other exotic animals. Experts from Europe and the United States will share their knowledge on ophthalmological examination, husbandry and handling techniques of these animals. In addition, clinical cases, scientific research and advances in the field will be presented, providing a unique opportunity to learn from leaders in veterinary ophthalmology.

Our Participation in ECVO 2024

As leaders in the field of ophthalmic nutraceuticals, we at Dr+Vet are committed to the advancement of veterinary ophthalmology and the ocular care of our pets. During the congress, we will have the opportunity to present our latest advances in ophthalmological products, share our expertise and establish connections with other professionals in the industry. It is also a good opportunity to get a closer look at our products and we will be happy to introduce you to our range and discuss how they can benefit your patients!

See you at ECVO 2024!


Miniatura-de-YouTube-Plan-de-Negocio-Sencillo-Moderno-Azul-1-1200x675.png
10/Apr/2024

On Wednesday 3rd April, Dr+Vet was honoured to welcome leading veterinary ophthalmologist Maria Simó for our first webinar on Keratoconjunctivitis Seca (KCS) in dogs. During this virtual event, María Simó shared her knowledge and experience in the diagnosis and treatment of this common but often underestimated eye disease. Today, we can finally announce that the full video, with subtitles in English (and other languages automatically), is available for viewing on our blog and our YouTube channel! Attached to this article, you will find the direct link to the video so you can access it and deepen the knowledge shared by María Simó.

About Maria Simó:

Maria Simó is a renowned veterinary ophthalmologist with a solid background and extensive experience in the field of veterinary ophthalmology. Graduated in Veterinary Medicine from the Autonomous University of Barcelona, María has completed several postgraduate courses and works as an ophthalmologist at the prestigious Instituto Veterinario Oftalmológico (IVO) in Barcelona.

Contenido del Webinar:

Maria Simó talked us through the basics of Keratoconjunctivitis Seca, from diagnostic methods to the most effective treatment options, exploring in detail how to approach this disease in a comprehensive way.

One of the main conclusions of the webinar was the importance of not relying solely on the Schirmer test to diagnose KCS. María Simó emphasised the need for a complete and detailed assessment, as well as the use of additional diagnostic tools for a correct diagnosis, as without all the information, ineffective treatments may be prescribed. She also talked about the importance of referring cases that do not resolve correctly in order to fully evaluate them.

 

We thank all participants for their support.

The webinar on Keratoconjunctivitis Seca with Maria Simó was a great success, and we would like to thank everyone who joined us for this educational event. We hope that this resource will be a valuable source of information for all veterinarians interested in veterinary ophthalmology. Feel free to check out the full video and share it with your colleagues.

Stay tuned to our social media and website for more information on future of Dr+Vet events and educational resources!


Spain-1200x675.png
10/Apr/2024

Dr+Vet presents its new Guide to the Diagnosis and Management of Keratoconjunctivitis Seca in Companion Pets

We are pleased to announce the launch of our latest initiative: the Guide to the Diagnosis and Management of Keratoconjunctivitis Seca (KCS) in Companion Animals. This guide has been designed to provide veterinarians with a tool to address this common ocular pathology in pets.

KCS, also known as dry eye, is a disease that affects the ocular health of animals, causing discomfort and, in severe cases, permanent damage to the cornea and conjunctiva. To help veterinary professionals diagnose and treat this condition effectively, our guide covers a wide range of topics, from the pathophysiology of the disease to treatment options and recommendations for clinical management.

Some of the guide’s topics include:

  • A detailed description of the disease and its impact on the ocular health of animals.
  • Explanation of the different types of KCS and their clinical features.
  • Diagnostic methods.
  • Treatment options, from artificial tears to more advanced therapies.

At Dr+Vet, we want to assist in everyday clinical practice by providing valuable resources to help veterinarians provide the best possible care for their furry patients.

The Keratoconjunctivitis Sicca Diagnosis and Management Guide is now available for free download on our website – don’t miss this opportunity to improve your knowledge and skills in managing your patients’ ocular health!

Click here to download: Dr+Vet. Guide for KCS for veterinarians


Spain-1200x675.png
09/Apr/2024

Dr+Vet presents its new Guide to the Diagnosis and Management of Keratoconjunctivitis Seca in Companion Pets

We are pleased to announce the launch of our latest initiative: the Guide to the Diagnosis and Management of Keratoconjunctivitis Seca (KCS) in Companion Animals. This guide has been designed to provide veterinarians with a tool to address this common ocular pathology in pets.

KCS, also known as dry eye, is a disease that affects the ocular health of animals, causing discomfort and, in severe cases, permanent damage to the cornea and conjunctiva. To help veterinary professionals diagnose and treat this condition effectively, our guide covers a wide range of topics, from the pathophysiology of the disease to treatment options and recommendations for clinical management.

Some of the guide’s topics include:

  • A detailed description of the disease and its impact on the ocular health of animals.
  • Explanation of the different types of KCS and their clinical features.
  • Diagnostic methods.
  • Treatment options, from artificial tears to more advanced therapies.

At Dr+Vet, we want to assist in everyday clinical practice by providing valuable resources to help veterinarians provide the best possible care for their furry patients.

The Keratoconjunctivitis Seca Diagnosis and Management Guide is now available for free download on our website – don’t miss this opportunity to improve your knowledge and skills in managing your patients’ ocular health!

Click here to download: KCS Guide for veterinarians


Spain-1200x675.png
25/Mar/2024

Keratoconjunctivitis Sicca (KCS), also known as “dry eye,” is a common ophthalmic condition in dogs and cats that affects the ocular surface, specifically the cornea and conjunctiva.

This disease results from the deficiency of some of the phases of the tear film, which leads to tear hyperosmolarity and, consequently, a series of ocular complications that can compromise the visual health of the animal.

The structure of the tear

To better understand KCS, it is important to know the three layers that make up the tear film and their functions:

  • Mucinous layer: This layer, the innermost, modifies the surface tension of the tear so that it adheres and distributes properly over the surface of the eye. Mucin is produced and secreted mainly in conjunctival goblet cells.
  • Aqueous layer: The intermediate layer, and the most abundant, hydrates the ocular surface and transports nutrients and oxygen essential for the metabolism of the cornea. It also acts as a flushing mechanism to remove debris and foreign bodies. This watery portion is produced and secreted in the main and accessory lacrimal glands.
  • Lipid layer: The outermost layer protects the aqueous layer from evaporation, allowing the tear to remain in the eye longer. In addition, it increases the surface tension of the tear, preventing overflow over the edge of the eyelid and lubricating the eyelids. This layer is produced and secreted mainly in the meibomian glands.

KCS classification

The KCS can be classified into two main types:

  • Qualitative KCS: It is produced by a pathological decrease in the lipid or mucoid components of the tear film, which makes it difficult for it to remain on the cornea, either due to excess evaporation or difficulty adhering. It is usually due to damage or inflammation in the meibomian glands or goblet cells of the conjunctiva.
  • Quantitative KCS: It is produced by a pathological decrease in the aqueous component of the tear film. It can have various causes, the most common being localized and chronic immune-mediated inflammation of the lacrimal gland. This is the most common form of KCS, and in most cases it progresses to a mixed form (quantitative and qualitative) over time.

What symptoms does it cause?

Symptoms of KCS may include mucosal exudate, conjunctival hyperemia, corneal opacity, neovascularization, corneal edema, and ulceration, among others. The diagnosis of KCS requires a thorough evaluation of the patient’s medical history and specific ophthalmological tests, such as the Schirmer Test, Fluorescein Test, and the Lysamine Green Test.

What treatment is used?

Treatment of KCS may include artificial tears, topical immunosuppressants, and surgical treatments, depending on the severity and underlying cause of the disease. Additionally, supplementation with specific nutraceuticals such as LACRIMALIS+ can help manage this disease, offering natural help to maintain pets’ eye health.

 

If your pet presents symptoms compatible with this disease, go to your trusted veterinarian for correct diagnosis and treatment.


foto-para-dentro-drvet-1200x600.jpg
30/Apr/2023

On April 27th, we had the pleasure of sponsoring an exciting webinar organized by the European Society of Veterinary Ophthalmology (ESVO) on the use of nutraceuticals in veterinary ophthalmic practice. The event, brought together leading professionals in the field and members interested in exploring this very relevant topic.

During the webinar, Dr. Teresa Peña, a renowned expert in veterinary ophthalmology and associate professor at the Autonomous University of Barcelona, gave a keynote lecture on the most commonly used ingredients in veterinary ophthalmology and their role in the treatment of various eye diseases in animals. Dr. Peña delved into the scientific evidence supporting the use of these nutraceuticals, as well as the recommended protocols for their application in daily practice. His vast experience and expertise in the field provided attendees with a clear and detailed view of how these products can benefit the ocular health of our veterinary patients.

The webinar was an invaluable opportunity to learn and share knowledge with colleagues from around the world. It also provided a platform for the exchange of ideas and experiences, thus strengthening our professional community.

If you missed the webinar or simply wish to relive it, we invite you to access the full recording available at the following link:

Don’t miss it!


Copyright by Boothmen Pharma 2023. All rights reserved.